For Gene Haislip, a former official of the U.S. Drug Enforcement Agency (DEA), the perennial debate over Ritalin, the stimulant commonly prescribed for children with Attention Deficit Hyperactivity Disorder (ADHD), is an aching reminder of a moral battle he fought - and lost - to big drug companies.